Gene Query: DIEXF

Dataset Description Geneva Score
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 75.03
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 38.53
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 37.14
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 37.14
Total RNA-seq in ALL-SIL upon JQ1 inhibition 27.85
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 20.04
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 19.9
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 18.38
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 18.21
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 18.2
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 17.34
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 17.34
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 16.22
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 15.51
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 15.35
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 15.26
LNCaP treated with iBET 15.13
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 14.64
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 13.8
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 13.06
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 13.04
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 12.88
Differentially expressed genes post knock down of lincDUSP26 12.63
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 12.6
Differential analysis of gene regulation at transcript resolution by RNA-Seq 12.6
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 12.42
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 12.12
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 11.85
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 11.83
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 11.83
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 11.22
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 10.96
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 10.63
Effect of FGF13 depletion on the H460 cell line 10.56
Control of prostate tumour growth by the long non-coding RNA GHSROS 10.41
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 10.31
The landscape of alternative splicing in aggressive prostate cancers 10.29
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 10.04
Gene expression in PANC1 cells treated with Rakicidin 9.88
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 9.76
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.75
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 9.75
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 9.67
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 9.61
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 9.59
Functional role of SLIT2 and ROBO1 in trophoblasts 9.33
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.17
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.17
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 9.03
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 9.01
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 8.99
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 8.9
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 8.88
Fbxo32 mediated gene expression program underlies EMT and metastasis 8.83
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 8.81
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 8.81
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 8.7
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 8.63
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 8.59
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 8.59
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 8.56
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 8.48
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 8.47
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 8.23
IL-33 activates tumor stroma to promote intestinal polyposis 8.22
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 8.19
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 8.16
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 8.09
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 7.92
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 7.92
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 7.91
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 7.87
JunB control of keratinocyte-mediated inflammation [RNA-seq] 7.87
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 7.82
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.76
RNA Seq of HMVEC under hypoxia 7.65
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 7.65
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 7.6
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 7.56
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 7.54
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 7.45
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 7.45
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 7.44
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 7.4
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 7.33
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 7.31
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 7.26
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  6.99
Regulation of protein translation during mitosis 6.97
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 6.93
Dtx3L and Androgen Signaling in Prostate Cancer 6.89
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 6.88
Differential expression of genes in AD169-infected MRC5. 6.88
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 6.88
6.87
Transcriptomic analyssis following EHMT1/2 inhibition 6.84
The effect of PPARG inhibition on human angiomyolipoma cells 6.84
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 6.76
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 6.75
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 6.74
Effect of PRDM11 depletion in U2932 cells 6.73
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 6.72
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 6.72
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.61
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 6.49
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 6.48
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 6.48
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 6.44
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.41
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.41
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 6.38
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 6.37
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 6.33
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 6.22
AUF-1 affected genes in human skin cells 6.21
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 6.05
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 6.04
Genome-wide analysis of the Integrator complex (HTS) 6.01
Genome-wide analysis of the Integrator complex 6.01
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 5.98
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.96
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 5.95
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 5.94
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 5.9
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 5.88
U1 snRNP telescripting regulates size-function stratified human genome 5.88
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 5.88
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 5.86
ETV7 and interferon response 5.86
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 5.85
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 5.7
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 5.7
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 5.68
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 5.6
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 5.59
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 5.58
Chromatin-informed inference of transcriptional programs in gynecologic cancers 5.58
p53 activity results in DNA replication fork processivity 5.58
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 5.57
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 5.57
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 5.57
Global analysis of alternative splicing regulated by RBM10 5.47
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 5.46
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 5.46
RNA-seq of YB5 cells treated with Proscillaridin A 5.45
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 5.45
IMP3 regulated gene expression in breast cancer cells 5.43
Effect of drugs on transcriptomic profiles 5.42
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 5.41
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 5.4
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.4
RNA-seq in transgenic cells 5.39
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 5.38
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.38
Real-time observation of light-controlled transcription in living cells 5.38
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.37
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 5.33
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 5.33
Entrectinib Resistance in a Neuroblastoma Xenograft Model 5.32
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 5.32
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.32
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.31
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 5.3
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 5.3
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 5.3
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 5.3
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 5.3
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 5.23
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.22
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 5.22
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 5.22
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 5.14
RNA sequencing of matched nephrectomy samples [RNA-seq] 5.13
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 5.13
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.13
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 5.12
Developmental stage specific chromosome architecture in human erythroid cells 5.11
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 5.11
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 5.05
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 5.02
RNAseq of T-ALL upon long non coding rna purturbation 5.02
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.01
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 5.01
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 5.01
Crizotinib v. DMSO in SW480 cells 5.0
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.98
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 4.97
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.96
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 4.94
BAF controls genome accessibility 4.94
Targeting MTHFD2 in Acute Myeloid Leukemia 4.94
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.92
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.89
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.89
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 4.88
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 4.88
Gene expression alterations of pancreatic intraepithlial neoplasia 4.84
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 4.81
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 4.8
Systematic discovery of endogenous human ribonucleoprotein complexes 4.8
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 4.78
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 4.78
Expression level comparison under dividing and quiescent states in human primary fibroblasts 4.76
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 4.75
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 4.75
G-quadruplex structures mark human regulatory chromatin 4.74
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.7
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 4.66
Uridylation by TUT4 and TUT7 marks mRNA for degradation 4.65
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.65
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 4.65
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.64
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.62
FBXW7 modulates stress response by post-translational modification of HSF1 4.62
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 4.58
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 4.58
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 4.56
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.55
Differential Protein Occupancy Profiling of the mRNA Transcriptome 4.54
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 4.49
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 4.49
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 4.49
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.49
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.49
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 4.48
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.47
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 4.46
Transcriptome analysis upon C6orf203 silencing 4.44
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 4.43
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 4.42
Nucleoporin-mediated regulation of cell identity genes 4.4
The MEF2B Regulatory Network 4.39
The MEF2B Regulatory Network - RNA-seq data 4.39
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 4.36
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 4.36
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 4.36
Effect of disulfiram treatment on pediatric high grade glioma 4.32
Global Mapping of Human RNA-RNA Interactions 4.3
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 4.3
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.29
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.29
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 4.27
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 4.25
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 4.25
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 4.17
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 4.17
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.16
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.15
RNA sequencing of human mammary epithelial cells 4.14
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 4.13
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.12
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.12
MYC dependent mRNA translation shapes gene expression and cell biology 4.11
4sUDRB-seq: measuring transcription elongation and initiation genomewide 4.11
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 4.09
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 4.06
Genome-wide discovery of human splicing branchpoints 4.04
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 4.04
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 4.01
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 3.97
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 3.96
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.96
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 3.91
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.9
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.87
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 3.86
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 3.85
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.83
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.8
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.79
4sU-seq of HFF exposed to salt and heat stress 3.79
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 3.73
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.72
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 3.72
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 3.72
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 3.71
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 3.66
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.64
SLIGRL-induced gene expression changes in NHEK cells 3.64
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 3.57
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 3.57
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 3.53
ARID1A regulates condensin II distribution and chromosomal partition 3.53
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 3.52
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.51
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 3.5
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 3.49
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 3.46
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.44
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 3.42
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 3.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 3.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 3.41
Genome-wide discovery of human splicing branchpoints [RNAse] 3.34
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 3.33
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.32
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 3.31
DRB/GRO-Seq -/+ UV 3.31
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 3.29
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.28
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.26
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.26
SRSF1 role in cellular gene expression and splicing 3.25
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.23
RNA-seq analysis of breast cancer 3.22
RNA-seq analysis and shRNA screen of breast cancer 3.22
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.21
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 3.19
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 3.19
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 3.15
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 3.15
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 3.13
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 3.13
HEXIM1 is induced by DHODH inhibition to suppress melanoma 3.12
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 3.12
Gene expression analysis upon mtDNA depletion [RNA-seq] 3.1
Gene expression analysis upon mtDNA depletion 3.1
Hypoxic transcriptome of SQ20B human head and neck cancer cells 3.09
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.02
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 3.0
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.93
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.92
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 2.92
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 2.91
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 2.9
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.9
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.88
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 2.85
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 2.79
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 2.79
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.78
Noncoding regions are the main source of targetable tumor-specific antigens 2.77
RNA seq with AML (NB4) cells upon FTO inhibition 2.76
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.69
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 2.68
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 2.67
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 2.64
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 2.63
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 2.63
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.63
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 2.58
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.56
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 2.54
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 2.53
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.51
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 2.5
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 2.5
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.49
Gene expression profile in breast cancer cells 2.49
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.46
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.46
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.46
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.46
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.42
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.39
Transcriptome sequencing of K-562 cells 2.37
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.35
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.35
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 2.34
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.32
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.3
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.28
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 2.26
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 2.22
Transcriptome analysis of SKI knock-out in HL60 cells 2.22
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.22
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.19
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.18
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.18
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.14
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.12
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.07
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.04
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.03
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 1.96
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 1.96
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 1.9
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.85
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.85
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.85
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.83
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.8
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.8
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.79
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.78
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.78
Widespread intronic polyadenylation diversifies immune cell transcriptomes 1.77
Copper Regulation of HIF-1 Transcription Activity 1.75
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.75
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 1.74
High level DNA repair gene expression in human ES cells 1.72
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.72
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.71
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.71
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.69
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 1.67
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 1.66
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 1.65
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.6
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.6
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.6
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.6
N6-methyladenine DNA Modification in Glioblastoma 1.6
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 1.59
Determining mRNA half-lives on a transcriptome-wide scale 1.57
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 1.54
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.53
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.53
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.53
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.46
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.45
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.43
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 1.38
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.38
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.34
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.34
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.33
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.32
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.32
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.31
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.31
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.28
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.21
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.21
Effects of transcription on genome - nuclear lamina interactions 1.19
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.19
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.18
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.17
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.13
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.13
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.11
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.1
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 1.09
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.08
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.04
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.97
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.94
FOXP2's impact on the primate transcriptome 0.94
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.93
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.91
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.9
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.9
Myc activation coordinates gene transcription and protein translation responses 0.89
RNAseq analysis of ruxolitinib treated breast cancers 0.86
Modulation of nonsense-mediated decay by rapamycin 0.78
RNA seq_PDX2_SHP099 0.77
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.76
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 0.74
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.69
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.69
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.67
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.66
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 0.65
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.64
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.64
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 0.64
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.62
Transcriptome-wide modulation of splicing by the exon junction complex 0.61
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.61
Human Treg IFNg/IL-10 subpopulations 0.6
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.54
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.54
Functional significance of the HIV-1 Tat signature amino acid residues 0.54
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.54
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.53
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.5
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.5
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.46
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.46
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.4
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.38
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.35
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.32
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.29
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.27
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.26
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.25
Identification of the role of polydom in neurofibromas 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.24
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.23
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.22
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.2
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.2
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.19
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.17
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.17
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.12
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.1
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.09
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.09
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.07
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.06
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.06
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.03
Primary Human B-cell Temporal Response to CD40L Stimulation 0.01
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.01
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.01
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 0.0
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation